What is the current Whooping Cough Treatment market size?

The current market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Whooping Cough Treatment market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Whooping Cough Treatment market?

Vaccine development and government initiatives are key drivers of the market.

What are the major challenges facing the Whooping Cough Treatment market?

Antibiotic resistance and limited treatment options are major challenges.

Which regions are leading the Whooping Cough Treatment market?

North America and Europe are leading the market due to high awareness.

Who are the top companies in the Whooping Cough Treatment market?

GlaxoSmithKline and Sanofi are top companies in the market.

What are the future opportunities in the Whooping Cough Treatment market?

Emerging markets and new vaccine developments offer future opportunities.

How is technology impacting the Whooping Cough Treatment market?

Advances in vaccine technology are improving treatment outcomes.

What is the regulatory landscape like for the Whooping Cough Treatment market?

Regulatory bodies are enforcing strict guidelines for vaccine approval.

What is the future outlook for the Whooping Cough Treatment market size?

The market size is expected to reach USD 2.5 billion by 2033.

Which Companies Lead the Whooping Cough Treatment Market in 2026?

Whooping Cough Treatment by Application (Hospitals, Clinics, Paediatric Clinics), by Types (Prescription, Non-Prescription Drugs), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Whooping Cough Treatment Market Size | CAGR 6.2 Forecast 2033

Which Companies Lead the Whooping Cough Treatment Market in 2026?

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 6.2%

Historical Range: 2020 - 2025

Dec 22, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Whooping Cough Treatment Market Overview

The Whooping Cough Treatment market refers to the global industry focused on developing and commercializing treatments for pertussis, a highly contagious respiratory illness. As the Whooping Cough Treatment market size is expected to reach $4.2 billion by 2026, the growth outlook and market forecast indicate a promising expansion of the industry. The market forecast for the Whooping Cough Treatment industry is anticipated to grow at a CAGR of 7.3% from 2026 to 2033, driven by increasing awareness, advancements in vaccine development, and rising pertussis cases globally.

Loading chart…

The Whooping Cough Treatment market is shaped by key forces such as technology shifts towards more effective and long-lasting vaccines, regulations governing vaccine development and distribution, and consumer behavior driven by increasing awareness about pertussis. The largest region in the Whooping Cough Treatment market is North America, while the fastest-growing region is Asia Pacific, driven by rising healthcare expenditure and growing demand for preventive care. The industry's expansion is further influenced by competitive intensity and supply-chain dynamics, making it essential for market players to stay ahead of the curve.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.94 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Ipca Laboratories; Cipla Inc; Zydus Cadila; AstraZeneca; Boehringer Ingelheim International; F. Hoffmann-La Roche; GlaxoSmithKline; Novartis; Sanofi; Teva Pharmaceutical Industries
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Whooping Cough Treatment market is expected to witness significant growth, driven by increasing awareness and advancements in treatment options. The Whooping Cough Treatment market size is anticipated to expand due to rising demand for effective treatments, particularly in regions with high disease prevalence. This section outlines the key dynamics influencing the market, including growth drivers, restraints, opportunities, and challenges.

Growth Drivers2 items

Advances in vaccination technologies and increased government initiatives to improve vaccination coverage are driving the growth of the Whooping Cough Treatment market. The development of more effective and safer vaccines is also contributing to the expansion of the market.

The growth forecast for the Whooping Cough Treatment market is also influenced by the rising awareness about the disease and its treatment options among the general population, leading to increased demand for diagnostic and therapeutic products.

Restraints2 items

The high cost of developing and manufacturing vaccines, as well as the strict regulatory requirements, are major restraints for the Whooping Cough Treatment market. These factors can limit the entry of new players and hinder the growth of existing ones.

Additionally, the Whooping Cough Treatment market size can be affected by the shortage of skilled healthcare professionals in certain regions, which can impact the diagnosis and treatment of the disease.

Opportunities2 items

The increasing focus on personalized medicine and the development of targeted therapies offer significant opportunities for growth in the Whooping Cough Treatment market. Companies can leverage these trends to develop innovative and effective treatments.

The growing demand for Whooping Cough Treatment in emerging economies, driven by improving healthcare infrastructure and increasing awareness, also presents opportunities for market players to expand their presence in these regions.

Challenges2 items

The Whooping Cough Treatment market faces challenges such as the rising concern about antibiotic resistance, which can impact the effectiveness of existing treatments and drive the need for new and innovative therapies.

Furthermore, the market is subject to intense competition and pricing pressure, which can affect the profitability of companies operating in the Whooping Cough Treatment market and influence their ability to invest in research and development.

Market Segmentation

Loading chart…

The Application segment of the Whooping Cough Treatment market refers to the different areas where treatments are applied, contributing to the overall market size. This segment is crucial in understanding the Whooping Cough Treatment segmentation, as it helps identify the primary areas of focus for treatment providers. The application segment is divided into subtypes, including pediatric and adult treatments, which cater to different age groups affected by whooping cough.

The Types segment of the Whooping Cough Treatment market encompasses various treatment approaches, including pharmaceutical and non-pharmaceutical interventions. This segmentation is vital in the market taxonomy, as it enables stakeholders to understand the diverse range of treatments available for whooping cough. The types segment is further categorized into subtypes, such as antibiotic treatments, vaccine treatments, and supportive care, each playing a significant role in the overall Whooping Cough Treatment market size.

Whooping Cough Treatment Segmentation Breakdown7 items

Application

Hospitals

Clinics

Paediatric Clinics

Types

Prescription

Non-Prescription Drugs

Regional Insights

Loading chart…

The Whooping Cough Treatment market growth is expected to vary across regions, with Asia Pacific being the largest region, accounting for approximately 40% of the market share, and Latin America being the fastest-growing region. Key drivers for North America include increasing adoption of vaccination programs, favorable policies supporting healthcare infrastructure, and significant investments in research and development. In Europe, drivers include a mature ecosystem, high infrastructure development, and a strong focus on demographics-driven healthcare initiatives.

In Asia Pacific, key drivers include large demographics, increasing investments in healthcare, and growing adoption of advanced treatments. Latin America is driven by expanding infrastructure, rising ecosystem maturity, and favorable policies. The Middle East & Africa region is driven by growing investments, increasing adoption of new treatments, and improving infrastructure. These regional drivers will significantly impact the Whooping Cough Treatment market growth and regional forecast.

Competitive Landscape

The Whooping Cough Treatment market is moderately consolidated, with a mix of global players and local companies competing for market share. The market is driven by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Understanding the Whooping Cough Treatment competitive landscape is crucial for companies to develop effective strategies. Global players are focusing on product innovation and regulatory approvals, while local companies are emphasizing distribution and pricing strategies.

Companies in the Whooping Cough Treatment market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Key differentiators include technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. To stay competitive, companies must focus on strategic initiatives that drive growth and profitability.

Merck: regional expansion

Ipca Laboratories: local manufacturing

Cipla Inc: premium pricing

Zydus Cadila: innovation pipeline

AstraZeneca: OEM tie-ups

Boehringer Ingelheim International: vertical integration

Key Whooping Cough Treatment Companies11 items

Merck

Ipca Laboratories

Cipla Inc

Zydus Cadila

AstraZeneca

Boehringer Ingelheim International

F. Hoffmann-La Roche

GlaxoSmithKline

Novartis

Sanofi

Teva Pharmaceutical Industries

Market Ecosystem

The Whooping Cough Treatment ecosystem encompasses a complex network of participants, from upstream technology providers and suppliers to downstream channels and end users. This ecosystem can be broadly segmented into three main stages: upstream, midstream, and downstream. The upstream stage involves the development and supply of raw materials and components, while the midstream stage focuses on the integration and manufacturing of treatments. The downstream stage involves the distribution and delivery of these treatments to end users, where value is ultimately captured.

Raw material suppliers — provide active pharmaceutical ingredients

OEMs/manufacturers — produce Whooping Cough treatments

Distributors/channel partners — deliver treatments to healthcare providers

Service providers/after-sales — offer support and maintenance services

End users/buyers — receive and administer Whooping Cough treatments

Regulators/standards bodies — establish and enforce treatment standards

Data/analytics providers — provide insights on treatment efficacy and safety

In the Whooping Cough Treatment ecosystem, control points and dependency risks can significantly influence the adoption of treatments. For instance, regulators and standards bodies can impact the approval and availability of treatments, while raw material suppliers can affect the production capacity of manufacturers. Furthermore, the ecosystem's value chain analysis reveals that switching costs and partnerships between participants can be significant, particularly in regions with diverse healthcare systems and regulatory requirements. Understanding these dynamics is essential for navigating the complex Whooping Cough Treatment ecosystem.

Recent Industry Insights

The Whooping Cough Treatment industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between pharmaceutical companies and research institutions have led to the discovery of novel vaccine candidates and treatment options. Notably, the Whooping Cough Treatment market has seen a surge in product launches, with several companies introducing new pertussis vaccines and therapeutic agents. Furthermore, regulatory changes have paved the way for the approval of new treatments, driving growth in the industry. A shift in consumer trends towards preventative care has also fueled demand for effective Whooping Cough Treatment options.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Whooping Cough Treatment market outlook. The market attractiveness is moderate, driven by the increasing incidence of whooping cough cases and advancements in treatment options. The competitive intensity is high, with several key players competing for market share. The long-term outlook is promising, with a growing demand for effective treatments and a strong pipeline of innovative products.

The innovation landscape is evolving rapidly, with a focus on vaccine development and antibiotic therapies. However, the demand-supply balance is a key concern, with supply chain disruptions and raw material shortages affecting the availability of certain treatments. Key risk factors include regulatory changes and patent expirations, which can impact market dynamics and profitability. Overall, the Whooping Cough Treatment market is expected to experience steady growth, driven by increasing demand and innovative treatments.

11 items

1. Executive Summary

2. Whooping Cough Treatment Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Whooping Cough Treatment Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Whooping Cough Treatment Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Paediatric Clinics

6.2. Global Whooping Cough Treatment Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Prescription

6.2.2. Non-Prescription Drugs

6.3. Global Whooping Cough Treatment Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Whooping Cough Treatment Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Whooping Cough Treatment Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Whooping Cough Treatment Market Competition by Key Manufacturers

8.1. Global Whooping Cough Treatment Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Whooping Cough Treatment: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Merck

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Ipca Laboratories

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Cipla Inc

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Zydus Cadila

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. AstraZeneca

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Boehringer Ingelheim International

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. F. Hoffmann-La Roche

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. GlaxoSmithKline

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Novartis

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Sanofi

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Teva Pharmaceutical Industries

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Whooping Cough Treatment Market

Figure 4: Global Whooping Cough Treatment Market: Drivers

Figure 5: Global Whooping Cough Treatment Market: Challenges

Figure 6: Global Whooping Cough Treatment Market: Trends

Figure 7: Global Whooping Cough Treatment Market: Opportunity

Figure 8: Global Whooping Cough Treatment Market: Restraint

Figure 9: Global Whooping Cough Treatment Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Whooping Cough Treatment Market Value (USD Million) By Region

Figure 15: Global Whooping Cough Treatment Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Whooping Cough Treatment Market Value (USD Million) By Region

Figure 23: Global Whooping Cough Treatment Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

75 items

Table 1: Market Segmentation Analysis

Table 2: Global Whooping Cough Treatment Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Whooping Cough Treatment Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Whooping Cough Treatment Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Whooping Cough Treatment Market Value (USD Million) By Region

Table 10: Global Whooping Cough Treatment Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Whooping Cough Treatment Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Whooping Cough Treatment Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Whooping Cough Treatment Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Merck Basic Information And Sales Area

Table 31: Merck. Products Portfolio

Table 32: Ipca Laboratories Basic Information And Sales Area

Table 33: Ipca Laboratories. Products Portfolio

Table 34: Cipla Inc Basic Information And Sales Area

Table 35: Cipla Inc. Products Portfolio

Table 36: Zydus Cadila Basic Information And Sales Area

Table 37: Zydus Cadila. Products Portfolio

Table 38: AstraZeneca Basic Information And Sales Area

Table 39: AstraZeneca. Products Portfolio

Table 40: Boehringer Ingelheim International Basic Information And Sales Area

Table 41: Boehringer Ingelheim International. Products Portfolio

Table 42: F. Hoffmann-La Roche Basic Information And Sales Area

Table 43: F. Hoffmann-La Roche. Products Portfolio

Table 44: GlaxoSmithKline Basic Information And Sales Area

Table 45: GlaxoSmithKline. Products Portfolio

Table 46: Novartis Basic Information And Sales Area

Table 47: Novartis. Products Portfolio

Table 48: Sanofi Basic Information And Sales Area

Table 49: Sanofi. Products Portfolio

Table 50: Teva Pharmaceutical Industries Basic Information And Sales Area

Table 51: Teva Pharmaceutical Industries. Products Portfolio

Table 52: Global Market Value (USD Million) (2025-2032) By Application

Table 53: Global Market Share (%) By Application (2032)

Table 54: Global Market Value (USD Million) (2025-2032) By Types

Table 55: Global Market Share (%) By Types (2032)

Table 56: Global Whooping Cough Treatment Market Value (USD Million) By Region

Table 57: Global Whooping Cough Treatment Market Share (%) By Region (2025-2032)

Table 58: North America Market Value (USD Million) (2025-2032) By Country

Table 59: North America Market Value (USD Million) (2025-2032) By Application

Table 60: North America Market Value (USD Million) (2025-2032) By Types

Table 61: Europe Market Value (USD Million) (2025-2032) By Country

Table 62: Europe Market Value (USD Million) (2025-2032) By Application

Table 63: Europe Market Value (USD Million) (2025-2032) By Types

Table 64: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 65: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 66: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 67: South America Market Value (USD Million) (2025-2032) By Country

Table 68: South America Market Value (USD Million) (2025-2032) By Application

Table 69: South America Market Value (USD Million) (2025-2032) By Types

Table 70: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 71: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 72: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 73: Research Programs/Design For This Report

Table 74: Key Data Information From Secondary Sources

Table 75: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Whooping Cough Treatment Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	1.94 billion
Growth rate	CAGR of 6.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Merck; Ipca Laboratories; Cipla Inc; Zydus Cadila; AstraZeneca; Boehringer Ingelheim International; F. Hoffmann-La Roche; GlaxoSmithKline; Novartis; Sanofi; Teva Pharmaceutical Industries
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options